I think the Q&A in the conference call was a useful way of gauging what the market's worried about.
Lot's of discussion about the trial result.
A question as to whether TLX250 would get approved in time for the October pass-through meeting.
The usual question about R&D spending.
A question about contingent consideration (this is all a bit complicated but the half-yearly has the details, page 28 onwards, there's a lot of it.)
My guess is that some in the market thought: short term revenue stabilising. Medium term revenue growth may be delayed. Long term revenue growth unsure. Expenses still going up. So they hit the exit.
---
It's certainly the case that Illucix will be the only revenue source for the next year at least- quite possibly more.
So it will be interesting to see how market growth goes in that time. If they managed growth of ~10% a quarter for the next couple of quarters I would be very pleased. I'd by pleased with a linear growth of $US10m/q frankly. CB put a lot of emphasis during the conference call that (a) theirs was the best product and (b) TAM would continue to grow. They're currently headed for 30% market share and $US100m, and any improvement on that would be very helpful to the share price.
It was also mentioned that other jurisdictions were more or less on track (Brazil a bit delayed). If these (particularly Europe) start to kick into gear in 2024 that will help too.
The company has very clearly decided to emphasise long term opportunities and having a broad program over short term optics. But, at some stage, they are going to have to demonstrate a commitment to growing outright profit as much as growing the company.
Just a reminder, they got kicked 15% last quarterly too.
- Forums
- ASX - By Stock
- TLX
- Ann: Q3 2023 Business Update to Accompany Quarterly Results
Ann: Q3 2023 Business Update to Accompany Quarterly Results, page-81
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$19.75 |
Change
0.230(1.18%) |
Mkt cap ! $6.609B |
Open | High | Low | Value | Volume |
$19.85 | $20.00 | $19.67 | $21.81M | 1.101M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1242 | $19.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.75 | 15196 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1242 | 19.700 |
1 | 160 | 19.670 |
1 | 1000 | 19.660 |
2 | 1137 | 19.650 |
1 | 4727 | 19.640 |
Price($) | Vol. | No. |
---|---|---|
19.750 | 15196 | 1 |
19.780 | 1500 | 1 |
19.800 | 5212 | 3 |
19.820 | 4727 | 1 |
19.840 | 1096 | 4 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online